e-learning
resources
Copenhagen 2005
Monday 19.09.2005
COPD - treatment I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Sertraline effects on dyspnea in patients with severe COPD
L. Lores, M. Palau, F. Andreo, X. Casas, C. Plans (Sant Boi, Viladecans, Spain)
Source:
Annual Congress 2005 - COPD - treatment I
Session:
COPD - treatment I
Session type:
Thematic Poster Session
Number:
1925
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Lores, M. Palau, F. Andreo, X. Casas, C. Plans (Sant Boi, Viladecans, Spain). Sertraline effects on dyspnea in patients with severe COPD. Eur Respir J 2005; 26: Suppl. 49, 1925
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Impact of moderate and severe exacerbations in severe COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Long-term effect of roflumilast on exacerbations in patients with severe to very severe COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 526s
Year: 2006
Prolonged effect of exacerbations on fatigue and depression in moderate clinically stable COPD
Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation
Year: 2010
Respiratory depression secondary to morphine use in a patient with COPD and refractory breathlessness
Source: Eur Respir J, 49 (5) 1601858; 10.1183/13993003.01858-2016
Year: 2017
Predictors of severe exacerbations in patients with moderate and severe asthma
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018
Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD
Source: Eur Respir J 2013; 41: 993-995
Year: 2013
Effect of dupilumab on severe exacerbations in asthma patients with and without lung function improvements
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020
Siccine acid effects in patients with exacerbation of severe COPD
Source: Annual Congress 2007 - New insights into the treatment of COPD
Year: 2007
Severe outcomes of COVID-19 among patients with COPD and asthma
Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020
Year: 2021
Two-year safety of targeted lung denervation in patients with moderate to severe COPD
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015
Impact of exacerbation of COPD on anxiety and depression symptoms and dyspnea in the activities of daily living
Source: International Congress 2015 – Rehabilitation, exercise, hospitalisation and COPD
Year: 2015
The efficacy and side-effects of varenicline in patients with mild to moderate chronic obstructive pulmonary diseases
Source: Annual Congress 2010 - Passive smoking
Year: 2010
Budesonide/formoterol in a single inhaler reduces severe and mild exacerbations in patients with moderate to severe COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 242s
Year: 2002
Once-daily glycopyrronium improves lung function and reduces exacerbations in severe-to-very severe COPD patients: The SPARK study
Source: Annual Congress 2013 –New bronchodilators for COPD management
Year: 2013
GERD and anxiety in patients with severe COPD
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Mechanisms of exacerbation of respiratory symptoms in patients with CHF
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006
Drivers of respiratory symptoms in COPD patients
Source: International Congress 2018 – Patient-reported outcomes and scores in COPD
Year: 2018
Cognitive impairment in patients hospitalized with acute COPD exacerbation
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in COPD and asthma
Year: 2014
Pretreatment with inhaled procaterol improves symptoms of dyspnea and quality of life in patients with severe COPD
Source: Annual Congress 2012 - COPD treatments: efficacy and safety
Year: 2012
Gender differences in exertional breathlessness in patients with mild COPD
Source: Annual Congress 2007 - Advances in respiratory muscles
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept